Search General Info
Search Education
Search Partnering Companies
Citranvi Biosciences
4:45 PM - 5:00 PM (EST), Monday, February 6, 2023 ・ Winter Garden
![CEO 2023 Logo](/sites/default/files/2022-08/264423_BIO_22_CEO_Logo-V.png)
Citranvi® Biosciences is a pre-clinical stage North Carolina company led by a seasoned leadership team with significant experience in technologies for clinical development and commercialization of vaccines. Citranvi® has obtained a worldwide exclusive license from the Dept of Defence (DoD) to develop vaccines utilizing it’s herpesvirus protein multimeric technology platform. Citranvi will first develop two multi-antigen vaccines against infectious diseases caused by (1) cytomegalovirus (CMV) and (2) Epstein-Barr virus (EBV) for which at present there are no licensed vaccines. The goal for Citranvi® is to advance the two vaccine candidates (CMV and EBV) into Phase 1 and Phase 2 clinical trials to evaluate safety and immunogenicity to support Phase 3 efficacy and safety trials needed for commercialization. Citranvi seeks investment capital to move the CMV and EBV vaccines into Phase 1 and 2 studies utilizing clinical trial vaccine materials and commercialization via partnerships.
![](/sites/default/files/hubb_images/6588/attachments/%2520-%2520f1_Citranvi_20Biosciences_996c6b1c.png)
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
North Carolina
Company HQ Country:
United States
Year Founded:
2020
Main Therapeutic Focus:
Infectious Diseases
Lead Product in Development:
Cytomegalovirus Vaccine
Development Phase of Primary Product:
Pre-Clinical
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
![photo](/sites/default/files/hubb_images/6588/photos/user1.Prasad.28eaac77.jpg)
BIO DOUBLE HELIX SPONSORS
![Sanofi logo](/sites/default/files/2022-05/Sanofi_Color_jpg_Double%20Helix.jpg)
![Eli Lilly and Company](/sites/default/files/2019-09/Eli%20Lilly%20and%20Company.png)
![Amgen logo](/sites/default/files/2022-05/Amgen_Color_png_Double%20Helix.png)
![Genentech logo](/sites/default/files/2022-05/Genentech_Color_png_Double%20Helix.png)
![Merck_logo_2022](/sites/default/files/2022-10/Merck_Color_.png)
![Avantor](/sites/default/files/2021-06/Avantor-BIO-DH-578.png)
![GSK logo](/sites/default/files/2023-04/gsk_color_png.png)
BIO HELIX SPONSORS
![Johnson and Johnson](/sites/default/files/2021-06/Johnson-Johnson-BIO-DH-578.png)
![Takeda logo](/sites/default/files/2022-05/Takeda_Color_jpg_Premier.jpg)
![Travere logo](/sites/default/files/2022-05/Travere_Color_png_Helix%20large.png)
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2024 All Rights Reserved